Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1633, 2008-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
More aggressive targeting of LDL-cholesterol warranted
Inpharma, Vol. 1, Iss. 1306, 2001-01 ,pp. :
Access to resources
Recommend
COX-2s confer QOL benefit in clinical practice in Latin America
Inpharma, Vol. 1, Iss. 1448, 2004-01 ,pp. :
COX-2s confer QOL benefit in clinical practice in Latin America
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 458, 2004-01 ,pp. :
Aggressive lowering of LDL-cholesterol preferable?
Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. :
LDL-cholesterol targets: lower is better, no matter what method
Inpharma, Vol. 1, Iss. 1655, 2008-01 ,pp. :